Double approval, double acquisition, $200M for tests, $200M for prostate robots, $450M for $1B worth of gummies

Originally Published as The Niche Podcast.

Find out more at
https://LifeScienceTodayPodcast.com

Story References
https://tinyurl.com/Niche-070-1
https://tinyurl.com/Niche-070-2
https://tinyurl.com/Niche-070-3
https://tinyurl.com/Niche-070-4
https://tinyurl.com/Niche-070-5
https://tinyurl.com/Niche-070-6
https://tinyurl.com/Niche-070-7

About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. You can expect highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.